According to the Ministry of Food and Drug Safety, Wegovy, an obesity treatment developed by Danish pharmaceutical company Novo Nordisk, will be released in Korea on the 15th
Increasing clinical research and emerging approvals for GLP-1 therapies in younger populations are enabling safer and more effective treatment options for adolescents
Class Ia: Quinidine, Procainamide, Disopyramide Indications: Supraventricular tachyarrhythmias, recurrent atrial fibrillation, ventricular tachycardia (VT), ventricular fibrillation (VF), Brugada syndrome, short QT syndrome (SQTS) (15)(16)(18)
When injected subcutaneously, the peptide reaches peak plasma levels within 1-3 hours and is cleared relatively rapidly, likely through peptidase degradation and renal filtration
Rumor vs Truth: GLP-1 Side Effects Are GLP-1 side effects food for thought or just food for rumors